The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lancaster James C Jr since 2007.
The trader's CIK number is 1396927.
At the time of the last reporting, Lancaster James C Jr was the VP of Commercial Ope of Orexigen Therapeutics, Inc.. (stock ticker symbol OREXQ).
Also see all insider trading activities at Orexigen Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | OREX | 0 | $0 | 6,000 | $88,311 | 6,000 | $12,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-12-26 | OREX | Sale | 3,000 | 15.02 | 45,072 |
| 2007-12-26 | OREX | Option Ex | 3,000 | 2.00 | 6,000 |
| 2007-11-26 | OREX | Sale | 3,000 | 14.41 | 43,239 |
| 2007-11-26 | OREX | Option Ex | 3,000 | 2.00 | 6,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lancaster James C Jr (VP of Commercial Ope of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.